Live Breaking News & Updates on Llison deangelis

Stay informed with the latest breaking news from Llison deangelis on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Llison deangelis and stay connected to the pulse of your community

List: the 17 Fastest-Growing Biotechs and Pharmas of 2021

Insider analyzed hundreds of life-science companies to identify the 17 drug developers that are growing the fastest.

Germany , New-york , United-states , India , United-kingdom , Denmark , China , California , San-diego , Dallas , Texas , San-francisco

JPMorgan Banker: Biotechs Should Prepare for Rare Down Rounds

Biotech valuations hit a 10-year high last year. But poor IPO options and an M&A lull means startups may need to raise down rounds.

Biotech , Rivate-equity , Enture-capital , Own-rounds , Aluations , Tartups , I-prime , Ispensed , Llison-deangelis ,

Exclusive: Flagship-Backed Biotech Kaleido Biosciences Cuts Staff

Exclusive: The Flagship Pioneering-backed Kaleido Biosciences is shedding staff, people tell Insider. It's developing drugs using the microbiome.

Biotech , Icrobiome , Lagship-pioneering , Aleido-biosciences , Ayoffs , I-prime , Ispensed , Llison-deangelis ,

Biotechs Lexeo, Shape Discuss Gene Therapies for Alzheimer's Disease

Biotechs Lexeo Therapeutics and Shape Therapeutics gave the public its first look at the one-and-done gene therapies they're creating for Alzheimer's.

New-york , United-states , California , San-diego , Danielle-brill , David-liu , Raymond-james , Nolan-townsend , Eli-lilly , University-of-california , Broad-institute , Lexeo-therapeutics

Omega Funds VC: Don't Go Public in Biotech Right Now

Omega Funds founder Otello Stampacchia said the biotech market was "fairly close to rock-bottom sentiment" and is advising companies not to go public.

Bi-prime , Iotech , Po , Tock-market , M-amp-a , Aluations , Enture-capital , Harmaceutical , Ealthcare , Ispensed , Ndrew-dunn

Pitch Deck: 64x Bio Raises $55 Million for Cell, Gene Therapy Tools.

Hundreds of cell and gene therapies are being held up because of difficulty manufacturing components. Here's the solution 64x Bio pitched to investors.

Johnson , Features , Iotech , Itch-decks , Ene-therapy , Anufacturing , Ell-therapy , Tartup , Ispensed , Ealthcare , Cience

Medicare Wants to Limit Biogen's Alzheimer's Drug Aduhelm to Trial Participants

The guidance is a blow for Biogen, which has struggled with sales of its new drug after a controversial FDA approval.

Biogen , Ealthcare , Ducanumab , Duhelm , Lzheimer-x27s-disease , Edicare , Edicare-advantage , Ealth-insurance , Ispensed , Llison-deangelis ,

List: 10 Biotech Takeover Targets for Pharma M&a in 2022

Analysts and investors think drug companies could spend up to $1.6 trillion on M&A this year. Here are the 10 companies they agree are up for grabs.

Massachusetts , United-states , Boston , California , New-haven , Connecticut , San-diego , Cambridge , Cambridgeshire , United-kingdom , Dublin , Ireland

28 Startups Biotech's Top VC Arch Venture Is Investing in Next

Arch Venture backed 28 startups in 2021, participating in financings ranging from a $3.8 million seed round to a $500 million Series B round.

San-diego , California , United-states , Texas , Chicago , Illinois , Recuro-health , Venture-partners , Bi-prime , Iotech , Enture-capital

FDA OKs First COVID-19 Pill From Pfizer

Pfizer's pill was highly effective at preventing hospitalizations and deaths among people who recently got COVID-19.

Health , Oronavirus , Da , Ntiviral , Harmaceutical , Fizer , Ovid-19 , Micron , Andemic , Ispensed , Nsider-healthcare